Denis Talbot is Professor of Cancer Medicine at the University of Oxford and Consultant Medical Oncologist at the Oxford University Hospitals NHS Foundation Trust. He has expertise in thoracic oncology, neuroendocrine tumours and drug development. Denis has published widely on early phase trials of agents targeting cell cycle regulatory proteins, growth factors, DNA repair, macrophage activation and apoptosis underpinned by translational research focused on proof of concept studies. Denis’ interests include research ethics, physician/patient communication skills and development of objective assessment tools for evaluating clinical skills. He is a member of the Lung Cancer CEG, Cancer Chemotherapy Information Group, BTOG Steering Committee, UKLCC, NCRI Lung Cancer Group and is past Chairman of the Specialist Advisory Committee for Medical Oncology and Central Oxford Research Ethics Committees. Denis has served on the ASCO Faculty, the Leukaemia and Lymphoma Research Fund Scientific and Medical Advisory Panel, Cancer Research UK Clinician Scientist Advisory Board and New Agents Committee. He chairs a number of Safety and Data Monitoring Committees for international lung cancer trials.